Active Ingredient: SILDENAFIL CITRATE
Proprietary Name: REVATIO
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N022473
Product Number: 001
Approval Date: Nov 18, 2009
Applicant Holder Full Name: VIATRIS SPECIALTY LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
